Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce several
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …

Chronic venous disease (CVD) is a common venous disorder of the lower extremities. CVD
can be manifested as varicose veins (VVs), with dilated and tortuous veins, dysfunctional …

Aims Sulodexide is a highly purified mixture of glycosaminoglycans that has been studied
for its anti‐albuminuric potential. Considering the effects of glycosaminoglycans on …

Sulodexide (SDX) is a highly purified glycosaminoglycan with antithrombotic and
profibrinolytic properties and reported benefits in thrombotic and atherosclerotic vascular …

Preeclampsia, an important cause of maternal and fetal morbidity and mortality, is
associated with increased sFLT1 levels and with structural and functional damage to the …

Localized scleroderma (morphea) is a chronic autoimmune disease of the connective tissue.
Its etiopathogenesis is unknown. Most often the disease affects the skin, but may also …

Sulodexide (SDX), a purified glycosaminoglycan mixture used to treat vascular diseases,
has been reported to exert endothelial protective effects against ischemic injury. However …

Introduction: Sulodexide represents a mixture of fast-moving heparin (FMH) and dermatan
sulfate (DS) and has been used for the management of venous diseases such as DVT and …

Background/Objectives: Sulodexide (SDX) is a drug known for restoring the glycocalyx,
thereby offering endothelial protection and regulating permeability. Additionally, it has …

Venous thromboembolism (VTE) is one of the most dangerous complications of cancer.
Oncological treatment, surgeries and advanced-stage cancer are only some of the risk …